BfArM — authorised 9 November 2016
- Marketing authorisation holder: Pfizer Limited
- Status: approved
🇩🇪 Ibrance in Germany
BfArM authorised Ibrance on 9 November 2016
Marketing authorisation
Ibrance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Germany
Frequently asked questions
Is Ibrance approved in Germany?
Yes. BfArM authorised it on 9 November 2016.
Who is the marketing authorisation holder for Ibrance in Germany?
Pfizer Limited holds the German marketing authorisation.